Congenital Shunts


Approximately 1 in 100 adults have congenital heart disease. Congenital heart defects (CHDs) can be characterized as simple, moderate, or severe in complexity, based on the morbidity and mortality associated with each of these lesions.

Echocardiography plays a central role in the screening and diagnosis of congenital shunts, and all pediatric and adult echocardiography laboratories should be accustomed to evaluating CHDs. Evaluation and management of adult CHDs requires detailed knowledge of (1) the original anatomy and physiology; (2) dynamic changes in anatomy and physiology that occur with time; (3) effects of adult diseases (e.g., systemic arterial hypertension, coronary artery disease) or conditions (e.g., pregnancy) on that physiology; (4) types of operative or transcatheter repair for each lesion, both current and historic; (5) presence and extent of possible postoperative residua, sequelae, and complications; (6) the echocardiographic appearance of different types of devices, expected sequelae, and potential complications; and (7) proper selection, performance, and interpretation of modalities required for anatomic imaging and hemodynamic assessment.

The goal of the echocardiographer is to define the defect, comment on the presence or absence of associated CHDs, and evaluate the residua or sequelae of unrepaired and repaired defects. Comprehensive use of echocardiography with Doppler facilitates the noninvasive assessment of ventricular and valvular function, atrial size, interatrial and intraatrial anatomy, connections of the pulmonary and systemic veins, and estimated intracardiac systolic and diastolic pressures. Used in combination with two-dimensional (2D) imaging, spectral and color Doppler echocardiography enable localization of native shunts, detection of residual shunts after intervention, measurement of flow velocity, and calculation of gradients across the shunts.

Transthoracic echocardiography (TTE) is the recommended modality for the initial evaluation of asymptomatic patients with an abnormal electrocardiogram or chest radiograph that is concerning for structural heart disease or an abnormal murmur auscultated during a physical examination. To avoid late sequelae of chronic volume or pressure loading, even asymptomatic patients with unrepaired defects should be referred for consideration of repair if there is significant chamber dilation or the next left-to-right shunt is sufficiently large enough to cause physiologic sequelae.

Repaired and unrepaired patients should have regular cardiology follow-up and lifelong surveillance echocardiograms because shunts may lead to late sequelae such as arrhythmias, heart failure, or residual or recurrent shunts from patch leaks. Echocardiography is the recommended imaging modality for initial and serial evaluation of symptomatic patients with symptoms of right- or left-sided heart failure, evidence of pulmonary hypertension, atrial arrhythmias, or endocarditis.

Transesophageal echocardiography (TEE) and intracardiac echocardiography (ICE) enable improved visualization of left-sided valves and the more posterior aspects of the heart. They can provide valuable information for diagnostic assessment and interventional guidance in CHDs. When questions remain, particularly regarding visualization of extracardiac structures, magnetic resonance imaging (MRI) or computed tomography (CT) provides useful additional information. Diagnostic cardiac catheterization remains important for confirmation of intracardiac and pulmonary artery pressures, confirmation of the degree of shunting, and preoperative evaluation of coronary arteries in the older adult.

When approaching cardiac shunts, it is helpful to differentiate between pre-tricuspid and post-tricuspid shunts based on whether the chamber receiving the flow is proximal or distal to the tricuspid valve (TV) ( Table 41.1 ). Pre-tricuspid shunts result in volume loading of the right heart and therefore in symptoms and echocardiographic findings of right heart dilation. Pre-tricuspid shunts do not frequently lead to significant pulmonary vascular disease.

TABLE 41.1
Characteristics of Pre-tricuspid Versus Post-tricuspid Shunts.
Parameters Pre-Tricuspid Shunts Post-Tricuspid Shunts
Chamber receiving shunt flow Systemic veins (IVC, SVC)
RA
Coronary sinus
RV
Pulmonary artery
Examples Atrial-level shunts
Secundum ASD
Primum ASD
Sinus venous defects
Unroofed coronary sinus
LV-RA septal defect
Anomalous pulmonary venous return
Partial anomalous pulmonary veins
Total anomalous pulmonary veins
VSD
PDA
Ruptured sinus of Valsalva aneurysm (aorta-to-RV shunt)
Hemodynamics Right heart volume loading RV pressure loading
Left heart volume loading
Echocardiographic findings RA dilation
RV dilation
Tricuspid regurgitation
Mildly to moderately elevated pulmonary pressures
Diastolic flattening of the ventricular septum
RV hypertrophy
LA dilation
LV dilation
Severely elevated pulmonary pressures if large shunt, and shunt reversal (Eisenmenger syndrome)
Systolic and diastolic flattening, ventricular septum
ASD , Atrial septal defect; IVC , inferior vena cava; PDA , patent ductus arteriosus; SVC , superior vena cava; VSD , ventricular septal defect.

The degree of shunting across pre-tricuspid shunts depends on the size of the defect and relative right ventricle (RV) and left ventricle (LV) compliance. Post-tricuspid shunts result in pressure loading of the RV and volume loading of the left atrium (LA) and LV. Patients with moderate or large post-tricuspid shunts may have symptoms of left heart failure, RV hypertrophy with eventual dysfunction and dilation due to chronically increased pressure afterload, and LA or LV dilation due to volume loading.

The degree of shunting across a post-tricuspid shunt depends on the size of the defect and relative pulmonary and systemic vascular resistance. Nonrestrictive post-tricuspid shunts result in progressive elevation of pulmonary vascular resistance and eventual shunt reversal (Eisenmenger syndrome) if not corrected during the first few years of life. Both types of pre-tricuspid and post-tricuspid shunts may lead to right heart failure. Coronary artery fistulas are typically small and do not result in significant volume load but may cause symptoms of coronary insufficiency.

The ratio of pulmonary blood flow (Qp) to systemic blood flow (Qs) can be determined noninvasively with Doppler echocardiographic measurements of stroke volume at two intracardiac sites ( Fig. 41.1 ). Most commonly, the Qp is calculated from the cross-sectional area (CSA) of the pulmonary artery and the velocity–time integral (VTI) gathered by a pulsed-wave Doppler sample at the site of area calculation; in patients with pulmonic valve stenosis, measurements may be made at the RVOT. In patients with pulmonary regurgitation, echocardiography should not be used to calculate Qp:Qs ratio. The Qs is calculated from the CSA of the left ventricular outflow tract (LVOT) and the LVOT VTI measured by PW Doppler. This method is reliable when 2D images are of sufficient quality for accurate measurements of the LVOT and right ventricular outflow tract (RVOT) or pulmonary artery diameters and when Doppler tracings are obtained parallel to flow. Small errors in 2D measurements can result in unreliable calculated values. If there are inconsistencies between the Qp:Qs ratio calculated from echocardiographic measurements and other echocardiographic or clinical findings, a cardiac catheterization should be performed, and pulmonary and systemic blood flow should be calculated using the Fick equation.

Fig. 41.1
Calculation of pulmonary blood flow (Qp) and systemic blood flow (Qs).
Pulmonary blood flow is equal to the cross-sectional area (CSA) of the pulmonary artery (PA) multiplied by the velocity–time integral (VTI) of pulmonary artery blood flow measured at the same site. Systemic blood flow is similarly measured using the LV outflow tract (LVOT) diameter and LVOT VTI.

Atrial-Level Shunts

Overview

Atrial septal defects (ASDs) account for approximately 10% of all congenital cardiac defects and occur in approximately 4 of every 100,000 newborns. ASDs account for 25% to 30% of CHDs diagnosed in adults. Three common types of defects result in interatrial shunts: secundum ASD, primum ASD, and sinus venosus defects ( Fig. 41.2 ). A fourth type, the unroofed coronary sinus, is rare.

Fig. 41.2, Atrial-level shunts.

The degree of shunting depends on relative ventricular compliance, which is determined by ventricular afterload. In a newborn with an isolated ASD, the RV is relatively thick and noncompliant due to elevated pulmonary vascular resistance in the fetal circulation. As the pulmonary vascular resistance decreases in the first months of life, RV hypertrophy regresses and the RV becomes more compliant than the LV, resulting in increased left-to-right shunting.

Individuals with small- to moderate-sized defects may remain asymptomatic until adulthood. As individuals age, the compliance of the LV decreases and LA pressures increase, resulting in even greater left-to-right shunting. After several decades of chronic right heart volume overload, patients may present with atrial arrhythmias or right heart failure.

Unexplained dilation of the RA and RV on TTE should trigger further evaluation for pre-tricuspid shunting. If no shunt is readily apparent on TTE, a TEE and/or cardiac CT or MRI should be considered. Atrial arrhythmias are uncommon in patients younger than 40 years of age. Mild to moderate pulmonary hypertension is common; severe pulmonary hypertension occurs in 5% to 10% of patients with unrepaired ASDs, predominantly in women. The cause of severe pulmonary hypertension in this minority of patients with ASDs is unclear. It appears to be unrelated to the degree of shunting and may represent the coexistence of idiopathic pulmonary arterial hypertension and an atrial-level communication.

Management

For all types of ASDs, repair is indicated if symptoms are present. For asymptomatic patients, repair should be considered to avoid late sequelae if right heart enlargement is identified or the Qp:Qs ratio is greater than 1.5:1. Severe pulmonary hypertension (i.e., pulmonary artery systolic pressure or pulmonary vascular resistance greater than two thirds of the systemic resistance) and net right-to-left shunting are contraindications to ASD closure. In selected cases, pulmonary vasodilators may decrease the pulmonary vascular resistance sufficiently to allow closure, and closure may improve functional capacity.

There are unusual cases of right-to-left shunting through an atrial communication in the absence of pulmonary hypertension; a variety of mechanisms may cause this, including medially directed tricuspid regurgitation, inferior vena cava (IVC) flow directed toward the atrial communication by the eustachian valve, and decreased right heart compliance, as in repaired pulmonary atresia with an intact ventricular septum. In such cases, patients may benefit from ASD closure, but provocative testing with transient defect balloon occlusion and volume loading may be necessary to avoid subsequent elevations in RA pressure.

Post-repair TTE should include evaluation of chamber sizes and tricuspid regurgitation, evaluation for new or worsening mitral regurgitation, and evaluation for residual shunting. RA and RV dilation typically improves in the first 3 to 6 months after ASD closure, although persistent dilation and tricuspid regurgitation are common in patients with large shunts repaired later in life. Mitral regurgitation may increase after ASD closure in 10% to 30% of patients; this occurs more often in older patients and in those with atrial fibrillation, LA dilation, or tricuspid regurgitation. , Late postoperative recurrence of RA and RV dilation warrants close echocardiographic evaluation for residual shunting from the device or surgical patch leaks or the worsening of pulmonary arterial hypertension. Comprehensive echocardiographic assessment of chamber sizes, ventricular function, and pressure estimation is imperative before and after ASD closure.

Secundum Atrial Septal Defect

Overview

Secundum ASDs are the most common type of ASDs, accounting for approximately 75% of cases. The ostium secundum is a normal gap in septum that allows blood to bypass the lungs in the fetal circulation. During embryologic atrial septation, the ostium secundum is normally occluded by the septum secundum as it grows from the roof of the common atrium toward the crux of the heart. Secundum ASDs may result from inadequate growth of the septum secundum, which leads to persistence of the ostium secundum.

The size of secundum ASDs varies widely, from small fenestrations in the fossa ovalis to very large defects with minimal rims. They can be round or oval and may be single or multiple. Small defects typically do not result in any measurable degree of right heart enlargement or pulmonary hypertension and may not be readily apparent on TTE. Moderate to large defects can usually be identified on TTE. Dropout in the area of the fossa ovalis is common, and the presence of a shunt should be confirmed with color Doppler. Spectral Doppler should then be used to confirm the direction of flow across the shunt, which can be predominantly left-to-right, right-to-left, or bidirectional ( Fig. 41.3 ). The subcostal view is optimal for color imaging of flow across the ASD because the direction of flow is parallel to the ultrasound beam.

Fig. 41.3, Secundum atrial septal defect.

Agitated saline contrast studies can be used to confirm right-to-left interatrial shunting when there is uncertainty about the presence of an interatrial shunt on 2D imaging and color Doppler, but differentiating a patent foramen ovalis from a small ASD requires TEE for most adult patients. During an agitated saline contrast study, absence of agitated saline contrast adjacent to the interatrial septum due to inflow of blood without agitated saline contrast is called negative contrast . However, because superior vena cava (SVC) flow also streams along the interatrial septum, the presence or absence of negative contrast should be considered together with other echocardiographic findings to confirm an ASD.

Management

Transcatheter closure of secundum ASDs has replaced traditional surgical ASD closure in most cases. The feasibility of device closure depends on the size of the defect, adequacy of the tissue rims, proximity to valves and pulmonary veins, and whether any other CHD (e.g., anomalous pulmonary veins) is present ( Table 41.2 ). These data are readily obtained with TEE imaging. The echocardiographer should interrogate the ASD at multiple angles to assess all rims ( Fig. 41.4 ). ASDs are dynamic, and their dimensions vary throughout the cardiac cycle. The echocardiographer should report the maximal diameter of the defect in two orthogonal planes to assist with device selection.

TABLE 41.2
Echocardiographic Evaluation of Secundum Atrial Septal Defects.
Presence and depth of rims
Relationship to atrioventricular valves, SVC, IVC, pulmonary veins
Dimensions (often oval and dynamic)
RA and RV size and function
Tricuspid and pulmonic regurgitation
Pulmonary artery dilation
RV and pulmonary artery pressure estimation
IVC , Inferior vena cava; PDA , patent ductus arteriosus; SVC , superior vena cava; VSD , ventricular septal defect.

Fig. 41.4, Atrial-level shunts, en face view.

Three-dimensional (3D) TEE imaging is an important adjunct to 2D imaging. Multiplanar reconstruction ensures that the defect is measured accurately. TEE images can be rotated to demonstrate the defect from the RA or LA side. If 3D images are being used to guide intervention, it is recommended that images be displayed in a standard format with the SVC at 12 o’clock from the RA view and the right upper pulmonary vein at 1 o’clock from the LA view to orient the image for the operator performing the transcatheter interventions ( Fig. 41.5 ).

Fig. 41.5, Evaluation of atrial septal defect by TEE.

Amplatzer septal occluders and Gore ASD occluders are approved by the US Food and Drug Administration (FDA) for percutaneous ASD closure ( Fig. 41.6 ). Previously, percutaneous ASD closure was limited to ASDs that are smaller than 30 mm in diameter and have at least 5 mm of circumferential rims. However, larger defects and defects with deficient rims have been closed successfully and with minimal complications. Potential complications of ASDs include arrhythmias, device erosion, perforation, pericardial effusion, thromboembolic events, device embolization, and allergic reactions to the nickel alloy contained in the device.

Fig. 41.6, Atrial septal occluder devices.

ASD closures can be performed under ultrasound guidance with TEE or ICE. The advantage of ICE is that a single operator can maneuver the ICE catheter and deploy the device with the patient under moderate sedation. Disadvantages are the learning curve associated with operating the ICE catheter, difficulty visualizing and assessing all rims and pulmonary venous connections, and limited sector width for guiding closure of larger defects. TEE guidance requires a second operator, and patients require deep sedation or general anesthesia for the duration of the procedure because of the discomfort of prolonged intubation with the TEE probe. However, TEE allows a more comprehensive evaluation of the rims in larger defects.

During transcatheter ASD closure, a right heart catheterization is performed, and measurements of hemodynamics and saturations are obtained. A wire is advanced from a femoral vein, across the ASD, and into the left upper pulmonary vein under TEE/ICE and fluoroscopic guidance. A sizing balloon is advanced over the wire across the defect and inflated with a mixture of saline and iodinated contrast until flow across the ASD is completely obstructed by the inflated balloon and a discrete narrowing (i.e., waist) is seen in the balloon. The diameter of the waist is referred to as the stretched diameter of the defect; it is measured on both TEE and fluoroscopic images to guide device selection. The stretched diameter is typically 10% to 20% larger than the corresponding diameter on baseline images.

The echocardiographer must ensure that there is no residual shunting at this point. If flow continues to occur across the septum, a second defect could be present, or the balloon may need to be inflated further to seal the defect completely and give the most accurate measurement. The balloon is then slowly deflated until a small amount of flow is observed and then reinflated another few milliliters until cessation of flow is again seen; the balloon waist at this point is called the stop flow diameter . The stop flow diameter is typically used to guide selection of the device size.

The delivery sheath is advanced over a wire, across the defect, and into the LA, and the closure device is then advanced through the sheath into the LA. The LA portion of the device is deployed with the catheter in the LA, and the catheter and device are then retracted together until the LA disk is flush with the LA aspect of the interatrial septum. The RA disk is then deployed. Before the device is released from the catheter, appropriate positioning is confirmed by interrogating all rims with 2D and color Doppler, and push/pull maneuvers are performed to confirm device stability. After the device is released, trace residual flow is expected and normal.

Repeat TTE is recommended within the first week after the procedure to ensure that a pericardial effusion has not developed and that the device is well seated. Agitated saline studies may remain positive at this first follow-up study, but residual shunting across the device typically resolves after the device is endothelialized, several months after the procedure.

Primum Atrial Septal Defects

Overview

Primum ASDs are part of the spectrum of atrioventricular septal defects (AVSDs), which are commonly called atrioventricular canal defects or endocardial cushion defects . AVSDs are caused by deficient formation of the atrioventricular (AV) septum from embryonic endocardial cushions, which results in a distinct malformation of the central fibrous cardiac crux.

AVSDs are characterized as partial, transitional, or complete. Isolated primum ASDs and isolated inlet VSDs are considered to be partial AVSDs. A transitional AVSD has a primum ASD and two AV valve annuli but abnormal left AV valve morphology. There is often a small inlet VSD that may be partly or completed closed by the chordal tissue of the AV valves. In the complete form of AVSD, a primum ASD and an inlet VSD exist, and there is one common AV valve. AVSDs are associated with trisomy 21 (i.e., Down syndrome), DiGeorge syndrome, Holt-Oram syndrome, and Ellis-van Creveld syndrome. Secundum-type ASDs and persistent left SVC are the most common anomalies associated with AVSD.

Unlike secundum ASDs, which are commonly diagnosed in adulthood, primum ASDs are more commonly diagnosed early in life because the atrial defect is usually large and the associated malformation of the AV valves often results in significant left AV valve regurgitation and heart failure symptoms. However, patients may be asymptomatic until adulthood if the degree of AV valve regurgitation is mild.

The cardiac crux and primum ASDs are well visualized in the apical 4-chamber view with TTE imaging. TEE is rarely necessary to establish the diagnosis, although it may be useful for further characterization of the AV valve. In AVSD, there is a common AV valve with five leaflets, rather than distinct mitral and tricuspid valves ( Fig. 41.7 ). The common AV valve is divided into left and right AV valves by the atrial or ventricular septum ( Table 41.3 ). The common AV valve may override both ventricles, or it may be unbalanced, predominantly draining into one fully formed ventricle and draining only partially into a hypoplastic second ventricle. Abnormal septal attachments are common.

Fig. 41.7, Atrioventricular septal defect.

TABLE 41.3
Differences Between Normal Mitral/Tricuspid Valves and Atrioventricular Valves in Patients With Atrioventricular Septal Defects.
Normal Valve Anatomy Atrioventricular Septal Defect
Septal attachment of the tricuspid valve is more apical than septal attachment of the mitral valve. Septal attachment points are at the same level.
Each mitral valve or tricuspid valve has its own annulus. The mitral valve annulus is saddle shaped. A common annulus encompasses the left and right valves.
Mitral valve morphology comprises anterior and posterior leaflets. Left AV valve has a cleft between the left-sided portion of the superior bridging leaflet and the left mural leaflet, leading to regurgitation. The inferior bridging leaflet serves as the posterior leaflet.
The tricuspid valve comprises septal, anterior, and posterior leaflets. Right AV valve comprises portions of the superior and inferior bridging leaflets, the right anterosuperior leaflet, and the right inferior leaflet.
AV , Atrioventricular.

The common AV valve results in anterior displacement of the aortic valve and elongation of the LVOT, and distortion of the LVOT may result in tunnel-like subaortic stenosis ( Fig. 41.8 ). Pulsed-wave Doppler imaging of the LVOT demonstrates flow acceleration in these cases. The term gooseneck deformity has been used to describe the angiographic appearance of the LVOT in patients with AVSD.

Fig. 41.8, Transitional atrioventricular septal defect.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here